CystoMedix

CystoMedix was a medical device company based in Anoka, Minnesota, that specialized in neuromodulation therapies for urological and pelvic floor disorders. The company is best known for developing the Urgent PC Neuromodulation System, which utilizes percutaneous tibial nerve stimulation (PTNS) to treat overactive bladder and associated symptoms like urge incontinence. This technology offers a minimally invasive, office-based alternative for patients who have not found relief through conservative treatments or medications. In April 2007, CystoMedix's intellectual property and assets were acquired by Uroplasty, Inc., a move that consolidated the commercialization of the Urgent PC system. The company also pioneered the Urgent-SQ, an implantable version of the device designed for long-term self-treatment. Today, the technology pioneered by CystoMedix remains a standard of care in the field of urology under the ownership of Laborie Medical Technologies.